Discover
XENE
Xenon Pharmaceuticals Inc.
66.74
1 x 66.00
1 x 67.63
bid
ask
+
0.00
0.00%
30 @ 04:00 PM
66.39 -0.35 (0.52%)
| Ytd | 48.91% | |
| 1y | 111.94% |
day range
30.00
52 week range
72.66
| Open | Prev Close | 66.74 | Low | High | Mkt Cap | 5.27B | |||
| Vol | 0.00 | Avg Vol | 1.44M | EPS | -4.70 | P/E | -14.20 | Forward P/E | -13.76 |
| Beta | 0.61 | Short Ratio | 3.56 | Inst. Own | 107.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 57.67 | 200-d Avg | 49.14 | 1yr Est | 80.56 |
| Income Statement | |||
| Operating Expenses | 112.33M | ||
| Research and Development Expense | 88.51M | ||
| Selling, General and Administrative Expense | 23.82M | ||
| Operating Income | -112.33M | ||
| Income Tax Expense | -2.57M | ||
| Net Income | -102.30M | ||
| Net Income Common Stock | -102.30M | ||
| Net Income Common Stock (USD) | -102.30M | ||
| Consolidated Income | -102.30M | ||
| Earnings per Basic Share | -1.17 | ||
| Earnings per Basic Share (USD) | -1.17 | ||
| Earnings per Diluted Share | -1.17 | ||
| Earning Before Interest & Taxes (EBIT) | -104.87M | ||
| Earning Before Interest & Taxes (USD) | -104.87M | ||
| Weighted Average Shares | 87.35M | ||
| Weighted Average Shares Diluted | 87.35M | ||
| Balance Sheet | |||
| Cash and Equivalents | 545.87M | ||
| Cash and Equivalents (USD) | 545.87M | ||
| Investments | 793.75M | ||
| Investments Current | 548.88M | ||
| Investments Non-Current | 244.87M | ||
| Trade and Non-Trade Receivables | 1.17M | ||
| Current Assets | 1.11B | ||
| Property, Plant & Equipment Net | 14.58M | ||
| Total Assets | 1.39B | ||
| Debt Current | 1.56M | ||
| Total Debt | 7.49M | ||
| Current Liabilities | 39.82M | ||
| Debt Non-Current | 5.93M | ||
| Total Liabilities | 48.99M | ||
| Accumulated Retained Earnings (Deficit) | -1.35B | ||
| Accumulated Other Comprehensive Income | -1.21M | ||
| Shareholders Equity | 1.34B | ||
| Shareholders Equity (USD) | 1.34B | ||
| Assets Non-Current | 280.18M | ||
| Total Debt (USD) | 7.49M | ||
| Liabilities Non-Current | 9.18M | ||
| Trade and Non-Trade Payables | 38.25M | ||
| Tax Assets | 12.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 925.00K | ||
| Net Cash Flow from Financing | 843.01M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 346.70M | ||
| Capital Expenditure | -133.00K | ||
| Issuance (Purchase) of Equity Shares | 843.01M | ||
| Net Cash Flow from Investing | -407.28M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -407.15M | ||
| Net Cash Flow from Operations | -88.90M | ||
| Effect of Exchange Rate Changes on Cash | -130.00K | ||
| Share Based Compensation | 16.89M | ||